Related Experiment Video

Updated: Jun 29, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

-(-)Gossypol promotes the apoptosis of bladder cancer cells in vitro

Jill A Macoska1, Shreelekha Adsule, Kwanchanit Tantivejkul

  • 1Department of Urology, The University of Michigan, Ann Arbor, MI 48109, United States. jcoska@med.umich.edu

Pharmacological Research
|October 9, 2008
PubMed

Insights

Gossypol, a natural compound, induces apoptosis in bladder cancer cells and enhances sensitivity to chemotherapy. This BH3 mimetic shows promise in overcoming chemoresistance and treating bladder cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Bcl2 family protein dysregulation correlates with poor bladder cancer chemotherapy response.
  • Targeting Bcl2 proteins offers a potential strategy to manage bladder cancer progression and metastasis.

Purpose of the Study:

  • To investigate if (-)-gossypol, a BH3 mimetic, can alter Bcl2 family protein expression in bladder cancer.
  • To determine if gossypol sensitizes bladder cancer cells to gemcitabine, paclitaxel, and carboplatin.

Main Methods:

  • In vitro studies using chemosensitive (UM-UC2) and chemoresistant (UM-UC9) bladder cancer cell lines.
  • Dose and time-dependent analysis of gossypol's effect on apoptosis.
  • Assessment of caspase-mediated pathways and Bcl2 family protein expression (Bcl-xl, Mcl-1, Bim, Puma).
  • Evaluation of gossypol in combination with standard chemotherapeutic agents.

Main Results:

  • Gossypol induced apoptosis in both cell lines via a caspase-mediated pathway.
  • Gossypol synergized with gemcitabine and carboplatin to enhance apoptosis in chemoresistant cells.
  • Gossypol treatment led to down-regulation of pro-survival proteins (Bcl-xl, Mcl-1) and up-regulation of pro-apoptotic proteins (Bim, Puma).

Conclusions:

  • Gossypol effectively induces apoptosis and sensitizes bladder cancer cells to chemotherapy.
  • Gossypol's modulation of Bcl2 family proteins is a key mechanism in overcoming chemoresistance.
  • Gossypol represents a promising therapeutic strategy for bladder cancer treatment.

More Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...